Large-scale testing (Phase 3)Study completedNCT00760435
What this trial is testing
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
Who this might be right for
Kawasaki Disease
University of California, San Diego 196